During the past decade, Department of Neurology and Hertie-Institute for Clinical Brain Research German Center of Neurodegenerative Diseases (DZNE) conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Department of Neurology and Hertie-Institute for Clinical Brain Research German Center of Neurodegenerative Diseases (DZNE)" #1 collaborator was "German Center for Neurodegenerative Diseases (DZNE)" with 1 trials as a collaborator and "German Research Foundation" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Department of Neurology and Hertie-Institute for Clinical Brain Research German Center of Neurodegenerative Diseases (DZNE)" are "Friedreich Ataxia" (2 trials), "Ataxia" (1 trials) and "Spastic Ataxia" (1 trials). Many other conditions were trialed in "Department of Neurology and Hertie-Institute for Clinical Brain Research German Center of Neurodegenerative Diseases (DZNE)" in a lesser frequency.

Most popular intervention types in "Department of Neurology and Hertie-Institute for Clinical Brain Research German Center of Neurodegenerative Diseases (DZNE)" are "Drug" (2 trials), "Other" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Vatiquinone" (2 trials), "Clinical rating scale to measure Ataxia disease severity and progression" (1 trials), "Clinical rating scale to measure ataxia disease severity and progression" (1 trials), "Clinical rating scale to measure spastic paraplegia disease severity and progression" (1 trials) and "Disease-specific severity index for adults with autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Department of Neurology and Hertie-Institute for Clinical Brain Research German Center of Neurodegenerative Diseases (DZNE)" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Department of Neurology and Hertie-Institute for Clinical Brain Research German Center of Neurodegenerative Diseases (DZNE)". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were undefined completed trials in Department of Neurology and Hertie-Institute for Clinical Brain Research German Center of Neurodegenerative Diseases (DZNE), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Department of Neurology and Hertie-Institute for Clinical Brain Research German Center of Neurodegenerative Diseases (DZNE), 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Department of Neurology and Hertie-Institute for Clinical Brain Research German Center of Neurodegenerative Diseases (DZNE) has several departments that took part in Clinical trials: "University Hospital Tübingen, Center for Neurology" - 6 trials, "University Hospital Tuebingen, Neurooncology" - 3 trials